Table 2 Response to therapy and organ assessment
| Cycles of chemotherapy | 6 |
|---|---|
| Patients available for survival analysis | 36 |
| Follow-up (mon) | 44 (31–59) |
| EFS (mon) | 39.5 (12–59) |
| Recurrence | 10 |
| Death | 1 (death from disease progression) |
| Response (available for response evaluation) | 36 |
| Better | 36 |
| Complete resolution (NAD) | 6 |
| Regressive disease | 30 |
| Organ resolution | |
| Bone lesions (imaging evaluation) | 31 |
| CR | 12 |
| PR | 19 |
| Bone aching | 18 |
| Complete regression | 14 |
| Partial regression | 4 |
| CNS lesions (imaging evaluation) | 25 |
| CR | 13 |
| PR | 12 |